ARS Pharmaceuticals (SPRY) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

ARS Pharmaceuticals (SPRY) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

ARS Pharmaceuticals

· SPRY

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

437.568 M

-2.05%

General

Market Cap: $437.57M
Enterprise Value: $591.44M
Shares Outstanding: 99,300,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 73.89%
Operating Margin: -184.96%
Net Profit Margin: -184.24%
FCF Margin: -168.14%
ROA: -86.35%
ROE: -256.67%
ROIC: -114.61%
Current Ratio: 3.48
Debt-to-Equity: 13.72
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.01
P/S: 3.66
P/FCF: —
P/B: 34.21
EV/EBITDA: -2.86

Growth

Rev 1Y: -5.46%
Rev 1Y Fwd Est: 54.14%
Rev 3Y (CAGR): 300.09%
Rev 5Y (CAGR): 36.42%
Rev 10Y (CAGR): —
EPS 1Y: -2327.91%
EPS 1Y Fwd Est: —
EPS 3Y (CAGR)

Income Statement (TTM)

Revenue: $116.93M
Gross Margin: 73.89%
Operating Expenses: $302.67M
Operating Income: -$216.27M
Net Profit: -$215.43M

Balance Sheet

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $8.16M
Working Capital: $150.65M
Total Assets: $249.5M
Net Debt: $163.44M
Total Liabilities: $236.98M
Total Equity: $12.51M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$196.41M
Cash Flow from Investing: $48.5M
Cash Flow from Financing: $104.53M
Free Cash Flow: -$196.6M
Capital Expenditures: $197K